Related Experiment Video
Updated: Sep 22, 2025
16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
11.7K
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
Jennifer M Pfaff-Kilgore1, Edgar Davidson1, Kathryn Kadash-Edmondson1
1Integral Molecular, Inc., 3711 Market St, Philadelphia, PA 19104, USA.
Cell Reports
|May 25, 2022
Summary
Hepatitis C virus (HCV) envelope proteins E1E2 are crucial for infection. This study reveals that 92% of amino acid mutations disrupt E1E2 function, highlighting targets for new therapies and vaccines.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Hepatitis C virus (HCV) E1 and E2 envelope proteins form a heterodimer essential for viral entry.
- Understanding E1E2 protein function is critical for developing effective HCV therapies and vaccines.
Purpose of the Study:
- To comprehensively analyze the functional role of each amino acid within the HCV E1E2 heterodimer.
- To identify critical residues and vulnerable sites on E1E2 for therapeutic targeting.
Main Methods:
- Generated 545 alanine mutants of the E1E2 complex in human cells.
- Assessed mutant functionality including translation, folding, heterodimerization, CD81 binding, and infectivity.
- Tested mutant interactions with 37 monoclonal antibodies (MAbs).
Main Results:
- A single alanine substitution at 92% of E1E2 positions significantly impaired protein function.
- Identified conserved and functionally critical amino acid residues within the E1E2 complex.
- Demonstrated that MAbs can neutralize HCV infection by targeting these vulnerable sites.
Conclusions:
- The HCV E1E2 protein complex is surprisingly fragile, with most residues being critical for function.
- The identified amino acid targets provide a basis for designing novel HCV vaccines and antiviral therapies.
